Novogenia AG (MUN:7V0)
Germany · Delayed Price · Currency is EUR 6.50
-0.10 (-1.52%)
Last updated: Oct 7, 2026, 8:00 AM CET
Novogenia AG Market Cap
Novogenia AG has a market cap or net worth of €78 million as of October 8, 2026. It is the 25,684th most valuable company in the world and the 350th biggest in Germany. Its market cap has decreased by 18.75% in one year.
Market Cap
78.00M
Enterprise Value
31.06M
Revenue
52.35M
Global Rank
Country Rank
#350 Germany
PE Ratio
n/a
ChartMarket Cap Chart
Since November 2, 2021, Novogenia AG's market cap has increased from 21.30M to 78.00M, an increase of 266.20%. That is a compound annual growth rate of 30.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 86.40M | -7.10% |
| Dec 22, 2025 | 93.00M | -14.36% |
| Dec 29, 2023 | 108.60M | -21.30% |
| Dec 30, 2022 | 138.00M | 88.52% |
| Dec 13, 2021 | 73.20M | 243.66% |
| Nov 2, 2021 | 21.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| 2invest AG | 43.75M |
| Biomark Diagnostics | 34.71M |
| Vidac Pharma Holding | 22.72M |
| Paion AG | 328.15K |
| bioXXmed AG | 244.68K |
| co.don AG | 213.79K |
| Medigene AG | 71.46K |